Methods and compositions for treating cancer
US11254912B2 · kind B2 · utility
5Cited by
45References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2021 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Apr 23, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein, in some embodiments, are methods and compositions (e.g., cell compositions) for the treatment of cancer. The methods and compositions involve genetically engineered immune cells (e.g., T cells), in which the endogenous CD70 gene is disrupted by genetic editing, for example, the CRISPR/Cas9 gene editing technology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.